A bedside guide to defining the problem space before choosing how to reason or act
How to use this guide
This is a rapid point-of-care orientation tool.
It helps you answer one question:
What kind of problem space am I in right now?
It does not tell you what to think or what to do. It defines the terrain so that your Thinking and Execution occur safely.
In the Consult Practice framework:
- Orientation defines the map
- Thinking determines stance within that map
- Execution translates that stance into visible action and communication
If Orientation is wrong, even excellent Thinking and Execution will occur in the wrong terrain.
What “problem space” means
A problem space describes:
- what kinds of explanations are plausible
- what kinds of danger must be considered
- how much uncertainty the situation can tolerate
- how fast the picture is evolving
Two patients with the same absolute neutrophil count may occupy completely different problem spaces.
Orientation defines which kind of uncertainty you are in, not which diagnosis is present.
Relationship to reference resources
Protocols, guidelines, and reference texts assume that the problem space has already been defined.
This guide helps you decide:
- which reference posture is appropriate
- whether urgency, surveillance, or restraint is the safer starting terrain
Orientation is complementary, not competitive.
Universal first check
Before interpreting neutropenia:
- confirm trajectory, not just the value
- assess clinical stability
- do not assume a shared process simply because one number is abnormal
Neutropenia is a signal. The question is what kind of terrain it signals.
Core orientation lenses
These are orients, not steps. They do not have to be addressed in order.
Each one constrains:
- what kinds of danger are plausible
- how much uncertainty is tolerable
- how fast Thinking and Execution should move
Orient 1 — How dangerous could this be right now?
Neutropenia can represent:
- immediate host defense failure
- a benign or reactive marrow pattern
- a chronic stable finding
Define:
- is the patient clinically unstable?
- is there evidence of infection or fever?
- does the count suggest acute vulnerability?
This orient constrains urgency, not diagnosis.
Orient 2 — Is this new, or expected in context?
Define whether the neutropenia is:
- new and unexplained
- chronic and stable
- physiologic or treatment-related
Counts that are expected in chemotherapy or chronic marrow conditions occupy a different terrain from sudden, unexplained neutropenia in an otherwise well patient.
Orient 3 — Is this isolated, or part of a broader hematologic pattern?
Look for:
- anemia
- thrombocytopenia
- pancytopenia
Isolated neutropenia often occupies a different problem space than neutropenia emerging as part of multi-lineage decline.
This orient defines the scope of the terrain.
Orient 4 — Does the clinical setting make marrow failure plausible?
Consider whether the terrain includes:
- acute marrow suppression
- chronic marrow disease
- peripheral destruction or redistribution
The purpose here is not to diagnose, but to define:
Does the clinical context make production failure a possibility that must be held?
That determines how broadly the situation should be viewed.
Orient 5 — What does trajectory suggest about tempo?
A rapidly falling ANC implies a different terrain than a stable or fluctuating count.
Define:
- is this evolving quickly?
- is the change proportional to illness or treatment?
- does the biology suggest an acute process or a chronic state?
This orient constrains how fast your Thinking and Execution should move.
A concrete comparison
| Patient | ANC | Context | Trajectory | Problem space |
|---|---|---|---|---|
| A | 0.8 | receiving chemotherapy | stable for weeks | expected treatment-related terrain |
| B | 0.8 | no prior hematologic disease | fell from 4.0 in 24 hours | acute vulnerability, evolving marrow or immune terrain |
Expected terrain does not imply safety. It describes context, not risk.
Same number. Different terrain. Orientation explains why.
Common traps to avoid
- treating neutropenia as a diagnosis rather than a pattern
- forcing a unifying explanation too early
- assuming chemotherapy is the only plausible terrain
- over-reassuring because the patient appears stable
- over-escalating without confirming trajectory
- ignoring the possibility that only one abnormality is clinically dangerous
Orientation protects against these early errors.
Functional problem spaces this guide identifies
This orientation helps define whether you are in:
- acute host defense risk terrain
- chronic or treatment-expected terrain
- marrow-failure or pancytopenic terrain
- peripheral or immune-mediated terrain
- an evolving picture requiring close surveillance
A patient may occupy more than one terrain at once. Early on, it is often safer to hold overlapping terrains than to force a single label.
Bottom line
Neutropenia is not a diagnosis.
Orientation answers:
- what kind of problem this might be
- how dangerous it could be
- how broad the terrain is
- how much uncertainty the moment can tolerate
Define the map first.
Then engage:
➡️ Thinking to choose how to reason
➡️ Execution to make judgment visible through action and communication
Terms used in this post
Problem space
The overall clinical terrain the patient occupies, including what explanations are plausible, what dangers must be considered, how fast the situation may evolve, and how much uncertainty can safely be tolerated. This is not a diagnosis. It is the world in which reasoning and action occur.
Orientation
The cognitive task of defining what kind of clinical world you are in before deciding how to reason or act. Orientation sets urgency, scope, and tolerance for uncertainty.
Thinking
The process of assigning and revising weight to possible explanations within a defined problem space. Thinking is about probabilities, trajectories, and trade-offs, not naming a final diagnosis.
Execution
The visible translation of judgment into action and communication. Execution includes what you prioritize, protect, escalate, defer, and how you make uncertainty and stance explicit to the team.
Terrain
A shorthand term for the clinical world created by the patient’s physiology, context, and trajectory. Different terrains carry different kinds of danger and demand different postures.
Trajectory
How a value or clinical state is changing over time, not just its current level. Trajectory often carries more meaning than a single snapshot.
Absolute neutrophil count (ANC)
A laboratory measure of circulating neutrophils used to assess infection risk. In this framework, ANC is treated as a signal whose meaning depends on context and trajectory.
Host defense risk terrain
A problem space in which neutropenia meaningfully increases vulnerability to infection and sepsis, requiring heightened vigilance and urgency.
Expected treatment-related terrain
A problem space in which neutropenia is anticipated (e.g., chemotherapy-related) and occupies a different risk and uncertainty profile than sudden, unexplained neutropenia.
Marrow-failure terrain
A clinical world in which impaired marrow production is plausibly contributing to cytopenias, broadening the scope of danger and requiring wider vigilance.
Peripheral or immune-mediated terrain
A problem space in which neutropenia reflects destruction, sequestration, or redistribution rather than primary marrow failure.
Uncertainty tolerance
How much ambiguity can safely be carried without escalating. This is defined by physiology, stability, and trajectory, not by comfort or preference.
Premature closure
Committing to a single explanation before the trajectory or evidence has earned that commitment, risking misclassification of the terrain.